Abeona Therapeutics Reports Q2 2026 Financial Results

What Happened Abeona Therapeutics Inc. announced its financial results for the quarter ended June 30, 2026 via a press release; the company filed an 8-K on August 13, 2026 (Item 2.02) to furnish that release. The press release is included as Exhibit 99.1 to the filing and the submission also includes the Inline XBRL cover page.

Key Details

• Filing date: August 13, 2026 (Form 8-K, Item 2.02 — Results of Operations and Financial Condition).
• Reporting period: quarter ended June 30, 2026.
• Exhibit included: Press release dated August 13, 2026 furnished as Exhibit 99.1.
• Inline XBRL cover page provided (Exhibit 104).

Why It Matters This 8-K provides Abeona’s latest quarterly results—earnings, revenue, and other operating and cash-flow details—used by investors to evaluate near-term performance and financial health. Retail investors should read the attached press release for the specific figures (revenue, net income/loss, R&D and SG&A expenses, and cash position) and any commentary from management that could affect outlook or valuation.